About this episode

David Rubin, MD discusses the gap between IBD therapies and patient outcomes, emphasizing treatment strategies and monitoring.

Despite more than 14 approved therapies for Crohn's disease and ulcerative colitis, many patients still aren't reaching remission. At DDW 2026, David Rubin, MD, of the University of Chicago Medicine explains why the problem isn't the drugs — it's how and when we use them. He covers early treatment strategies, treat-to-target monitoring, the induction pitfall, and when to switch mechanisms rather than cycling within class. Read more: https://www.hcplive.com/view/closing-the-gap-between-ibd-therapies-and-patient-outcomes-with-david-rubin-md

Explore listener stats, chart rankings, contacts and more on the HCPLive Podcasts podcast page.